(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(0.37%) $79.29
(0.88%) $1.949
(1.01%) $2 334.30
(1.05%) $27.03
(1.28%) $967.10
(0.04%) $0.933
(0.01%) $11.03
(-0.04%) $0.798
(0.06%) $93.51
Live Chart Being Loaded With Signals
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally...
Stats | |
---|---|
Šios dienos apimtis | 3 649.00 |
Vidutinė apimtis | 54 545.00 |
Rinkos kapitalizacija | 6.26M |
EPS | $0 ( 2024-03-20 ) |
Kita pelno data | ( $-1.350 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.160 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-05 | Zhao Jonathon Zhong | Buy | 0 | Common stock |
2024-03-05 | Zhao Jonathon Zhong | Buy | 0 | Series F Convertible Preferred Stock |
2024-01-18 | Patel Himanshu | Buy | 55 553 | Common Stock |
2024-01-18 | Patel Himanshu | Sell | 24 616 | Common Stock |
2024-01-18 | Soinski Jeffrey M | Buy | 74 071 | Common Stock |
INSIDER POWER |
---|
79.25 |
Last 96 transactions |
Buy: 1 530 711 | Sell: 343 509 |
Avinger Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
MPAA | 0.967 |
CAAS | 0.962 |
SXTC | 0.961 |
INVZ | 0.958 |
NVX | 0.958 |
PLUG | 0.957 |
ARVL | 0.956 |
BPYPN | 0.955 |
USEG | 0.954 |
ARDS | 0.954 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
BRIVU | -0.946 |
PPYAU | -0.941 |
TYHT | -0.933 |
RAM | -0.931 |
CPTA | -0.929 |
NVCN | -0.926 |
EVOP | -0.925 |
RPHM | -0.92 |
IMRX | -0.917 |
HSTM | -0.916 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Avinger Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $7.65M |
Bruto pelnas: | $2.00M (26.18 %) |
EPS: | $-23.31 |
FY | 2023 |
Pajamos: | $7.65M |
Bruto pelnas: | $2.00M (26.18 %) |
EPS: | $-23.31 |
FY | 2022 |
Pajamos: | $8.27M |
Bruto pelnas: | $2.65M (32.08 %) |
EPS: | $-41.83 |
FY | 2021 |
Pajamos: | $10.13M |
Bruto pelnas: | $3.42M (33.80 %) |
EPS: | $-4.57 |
Financial Reports:
No articles found.
Avinger Inc
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.